Drugs Made In America Acquisition Corp.

8-K Entered a material agreement Jul 20, 2026 10-Q Quarter ended 2026-03-31 May 14, 2026 8-K Entered a material agreement May 5, 2026 8-K Amended charter or bylaws; Shareholder vote results; Other events May 1, 2026 8-K Entered a material agreement Apr 28, 2026 10-K Fiscal year ended 2025-12-31 Apr 15, 2026 8-K Other events Apr 8, 2026 8-K Entered a material agreement; Took on a direct financial obligation; Other events Mar 27, 2026 8-K Other events Mar 6, 2026 8-K Director or officer change Mar 6, 2026 10-Q Quarter ended 2025-09-30 Nov 18, 2025 8-K Director or officer change Nov 18, 2025 10-Q Quarter ended 2025-06-30 Aug 14, 2025 10-Q Quarter ended 2025-03-31 May 20, 2025 10-K Fiscal year ended 2024-12-31 Mar 31, 2025 8-K Unregistered sale of equity; Other events Feb 25, 2025 8-K Other events Feb 24, 2025 8-K Other events Feb 4, 2025 8-K Entered a material agreement; Unregistered sale of equity; Amended charter or bylaws; Other events Jan 30, 2025 425 CURRENT REPORT Jul 20, 2026 SCHEDULE 13G Jun 26, 2026 SCHEDULE 13G May 14, 2026 425 CURRENT REPORT May 5, 2026 DEFR14A REVISED DEFINITIVE PROXY STATEMENT Apr 16, 2026 DEF 14A PROXY STATEMENT Apr 14, 2026 NT 10-K NOTIFICATION OF LATE FILING Apr 1, 2026 PRE 14A PROXY STATEMENT Mar 27, 2026 NT 10-Q NOTIFICATION OF LATE FILING Nov 17, 2025 SCHEDULE 13G/A Nov 12, 2025 SCHEDULE 13G/A Aug 14, 2025 SCHEDULE 13G May 15, 2025 NT 10-Q NOTIFICATION OF LATE FILING May 15, 2025 SCHEDULE 13G May 15, 2025 SCHEDULE 13G May 15, 2025 SCHEDULE 13G May 14, 2025 SCHEDULE 13G May 14, 2025 SCHEDULE 13D Mar 3, 2025 4 Feb 18, 2025 4 Feb 18, 2025 4 Feb 4, 2025